Biotech RadarJobs updated

COMPANY

Eluciderm

HQ: San Diego, CA source · eluciderm.com ↗

Clinical Phase 2

Eluciderm has developed a platform of small molecules that selectively modulate multiple Poly(ADP-ribose) polymerase (PARP) enzymes. From company website Source · Oct 12, 2026

Keywords: small molecules enzymes Diabetic Foot Ulcer Wagner Grade 1 - 2 Chronic Wound Open Wound ELU42

Location: San Diego, CA · source · Oct 13, 2026

Profile checked Oct 10, 2026

1Trials (company is sponsor)

Timeline

  1. Trial start Phase 1/Phase 2: Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers source ↗

Clinical trials (lead sponsor) 1

RecordTitlePhaseStatusStartPrimary completion
NCT07396376Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot UlcersPhase 1/Phase 2RecruitingNov 10, 2025Jun 1, 2026 (estimated)
Feedback